Ambarella, Inc. Announces Second Quarter Fiscal Year 2026 Financial Results
AMBARELLA, INC. | ||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
(in thousands, except share and per share data) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended July 31, | Six Months Ended July 31, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Revenue | $ | 95,511 | $ | 63,724 | $ | 181,383 | $ | 118,197 | ||||||||
Cost of revenue | 39,280 | 24,983 | 73,616 | 46,296 | ||||||||||||
Gross profit | 56,231 | 38,741 | 107,767 | 71,901 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 59,734 | 56,760 | 118,553 | 110,897 | ||||||||||||
Selling, general and administrative | 18,486 | 18,268 | 37,061 | 36,736 | ||||||||||||
Total operating expenses | 78,220 | 75,028 | 155,614 | 147,633 | ||||||||||||
Loss from operations | (21,989 | ) | (36,287 | ) | (47,847 | ) | (75,732 | ) | ||||||||
Other income, net | 2,247 | 2,145 | 4,422 | 4,416 | ||||||||||||
Loss before income taxes | (19,742 | ) | (34,142 | ) | (43,425 | ) | (71,316 | ) | ||||||||
Provision for income taxes | 253 | 747 | 898 | 1,505 | ||||||||||||
Net loss | $ | (19,995 | ) | $ | (34,889 | ) | $ | (44,323 | ) | $ | (72,821 | ) | ||||
Net loss per share attributable to ordinary shareholders: | ||||||||||||||||
Basic | $ | (0.47 | ) | $ | (0.85 | ) | $ | (1.05 | ) | $ | (1.78 | ) | ||||
Diluted | $ | (0.47 | ) | $ | (0.85 | ) | $ | (1.05 | ) | $ | (1.78 | ) | ||||
Weighted-average shares used to compute net loss per share | ||||||||||||||||
attributable to ordinary shareholders: | ||||||||||||||||
Basic | 42,546,979 | 41,129,754 | 42,383,475 | 40,952,373 | ||||||||||||
Diluted | 42,546,979 | 41,129,754 | 42,383,475 | 40,952,373 | ||||||||||||
The following tables present details of stock-based compensation and acquisition-related costs included in each functional line item in the condensed consolidated statements of operations above:
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||
(unaudited, in thousands) | |||||||||||
Stock-based compensation: | |||||||||||
Cost of revenue | $ | 780 | $ | 833 | $ | 1,731 | $ | 1,440 | |||
Research and development | 16,972 | 18,395 | 34,557 | 36,016 | |||||||
Selling, general and administrative | 7,436 | 8,384 | 15,030 | 16,192 | |||||||
Total stock-based compensation | $ | 25,188 | $ | 27,612 | $ | 51,318 | $ | 53,648 |
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||
(unaudited, in thousands) | |||||||||||
Acquisition-related costs: | |||||||||||
Cost of revenue | $ | 757 | $ | 757 | $ | 1,514 | $ | 1,514 | |||
Research and development | - | - | - | - | |||||||
Selling, general and administrative | 456 | 530 | 912 | 1,050 | |||||||
Total acquisition-related costs | $ | 1,213 | $ | 1,287 | $ | 2,426 | $ | 2,564 | |||
The difference between GAAP and non-GAAP gross margin was 1.6% and 2.5%, or $1.5 million and $1.6 million, for the three months ended July 31, 2025 and July 31, 2024, respectively. The difference between GAAP and non-GAAP gross margin was 1.8% and 2.5%, or $3.2 million and $3.0 million, for the six months ended July 31, 2025 and July 31, 2024, respectively. The differences were due to the effect of stock-based compensation and the amortization of acquisition-related costs.
AMBARELLA, INC. | |||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS (LOSSES) PER SHARE | |||||||||||||||
(in thousands, except share and per share data) | |||||||||||||||
Three Months Ended July 31, | Six Months Ended July 31, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||
(unaudited) | |||||||||||||||
GAAP net loss | $ | (19,995 | ) | $ | (34,889 | ) | $ | (44,323 | ) | $ | (72,821 | ) | |||
Non-GAAP adjustments: | |||||||||||||||
Stock-based compensation expense | 25,188 | 27,612 | 51,318 | 53,648 | |||||||||||
Acquisition-related costs | 1,213 | 1,287 | 2,426 | 2,564 | |||||||||||
Income tax effect | 22 | 448 | 36 | 600 | |||||||||||
Non-GAAP net income (loss) | $ | 6,428 | $ | (5,542 | ) | $ | 9,457 | $ | (16,009 | ) | |||||
GAAP - diluted weighted average shares | 42,546,979 | 41,129,754 | 42,383,475 | 40,952,373 | |||||||||||
Non-GAAP - diluted weighted average shares | 42,946,324 | 41,129,754 | 42,698,780 | 40,952,373 | |||||||||||
GAAP - diluted net loss per share | $ | (0.47 | ) | $ | (0.85 | ) | $ | (1.05 | ) | $ | (1.78 | ) | |||
Non-GAAP adjustments: | |||||||||||||||
Stock-based compensation expense | 0.59 | 0.68 | 1.21 | 1.32 | |||||||||||
Acquisition-related costs | 0.03 | 0.03 | 0.06 | 0.06 | |||||||||||
Income tax effect | 0.00 | 0.01 | 0.00 | 0.01 | |||||||||||
Effect of Non-GAAP - diluted weighted average shares | - | - | - | - | |||||||||||
Non-GAAP - diluted net income (loss) per share | $ | 0.15 | $ | (0.13 | ) | $ | 0.22 | $ | (0.39 | ) | |||||
AMBARELLA, INC. | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(unaudited, in thousands) | |||||||
July 31, | January 31, | ||||||
2025 | 2025 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 142,739 | $ | 144,622 | |||
Marketable debt securities | 118,444 | 105,643 | |||||
Accounts receivable, net | 42,896 | 29,767 | |||||
Inventories | 33,808 | 34,428 | |||||
Restricted cash | 442 | 7 | |||||
Prepaid expenses and other current assets | 5,543 | 6,084 | |||||
Total current assets | 343,872 | 320,551 | |||||
Property and equipment, net | 10,092 | 9,084 | |||||
Intangible assets, net | 41,879 | 47,279 | |||||
Operating lease right-of-use assets, net | 3,500 | 5,188 | |||||
Goodwill | 303,625 | 303,625 | |||||
Other non-current assets | 3,463 | 3,241 | |||||
Total assets | $ | 706,431 | $ | 688,968 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | 26,783 | 21,775 | |||||
Accrued and other current liabilities | 76,190 | 80,781 | |||||
Operating lease liabilities, current | 1,774 | 2,829 | |||||
Income taxes payable | 1,713 | 1,383 | |||||
Deferred revenue, current | 19,482 | 14,226 | |||||
Total current liabilities | 125,942 | 120,994 | |||||
Operating lease liabilities, non-current | 1,668 | 2,436 | |||||
Other long-term liabilities | 2,301 | 4,126 | |||||
Total liabilities | 129,911 | 127,556 | |||||
Shareholders' equity: | |||||||
Preference shares | - | - | |||||
Ordinary shares | 19 | 19 | |||||
Additional paid-in capital | 872,822 | 813,683 | |||||
Accumulated other comprehensive income (loss) | 59 | (233 | ) | ||||
Accumulated deficit | (296,380 | ) | (252,057 | ) | |||
Total shareholders' equity | 576,520 | 561,412 | |||||
Total liabilities and shareholders' equity | $ | 706,431 | $ | 688,968 | |||
Contact:
Louis Gerhardy
408.636.2310
...


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- United States Lubricants Market Growth Opportunities & Share Dynamics 20252033
- UK Digital Health Market To Reach USD 37.6 Billion By 2033
- Immigration Consultancy Business Plan 2025: What You Need To Get Started
- United States Animal Health Market Size, Industry Trends, Share, Growth And Report 2025-2033
- Latin America Mobile Payment Market To Hit USD 1,688.0 Billion By 2033
- United States Jewelry Market Forecast On Growth & Demand Drivers 20252033
Comments
No comment